Those who criticise so-called "me-too" drugs for being a wasteful use of resources overlook the vital pharmacological differences that come from the process of incremental innovation.
A new report from the Campaign for Fighting Diseases explores the so-called "10/90 Gap" - the idea that only 10% of global health research is devoted to conditions accounting for 90% of the global disease burden. The report shows that the 10/90 Gap is a myth.
In this paper, a group of experts from around the world contradict the claim that compulsory licensing of "essential" medicines will benefit the world's poor.
